31302-52-0

Basic information

• Product Name: 4-AMINOPHENYL-ALPHA-D-GLUCOPYRANOSIDE
• Synonyms: 4-AMINOPHENYL-ALPHA-D-GLUCOPYRANOSIDE;4-Aminophenyla-D-glucopyranoside;p-aminophenyl-alpha-D-glucopyranoside;alpha-D-Glucopyranoside 4-aminophenyl;alpha-D-Glucopyranoside p-aminophenyl
• CAS NO: 31302-52-0
• Molecular Formula: C₁₂H₁₇NO₆
• Molecular Weight: 271.26648
• EINECS: 1533716-785-6
• Mol File: 31302-52-0.mol
• Article Data: 7

Chemical Properties

• Melting Point: 185-186℃
• Boiling Point: 556℃
• Flash Point: 290℃
• Appearance: /
• Density: 1.517
• Storage Temp.: Hygroscopic, Refrigerator, under inert atmosphere
• Solubility: DMSO (Slightly), Methanol (Slightly, Heated, Sonicated)
• CAS DataBase Reference: 4-AMINOPHENYL-ALPHA-D-GLUCOPYRANOSIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-AMINOPHENYL-ALPHA-D-GLUCOPYRANOSIDE(31302-52-0)
• EPA Substance Registry System: 4-AMINOPHENYL-ALPHA-D-GLUCOPYRANOSIDE(31302-52-0)

Safety Data

• Hazardous Substances Data: 31302-52-0(Hazardous Substances Data)

Usage

Uses

4-Aminophenyl α-D-Glucopyranoside is a glycoside derivative of 4-Aminophenol (A618920); a nephrotoxic metabolite of Acetaminophen (A161220) and Phenacetin (P294580) (1).

Upstream product

• 3767-28-0 4-nitrophenyl-α-D-glucopyranoside 

Downstream Products

• 176757-24-7 4-(2,4-dinitrophenylamino)phenyl α-D-glucopyranoside 
• 1425814-76-1 C₂₈H₃₉ClN₂O₁₀ 
• 1309776-96-2 p-[N-(4-ethylamino-2,3-dioxocyclobut-1-enyl)amino]phenyl α-D-glucopyranoside 
• 1309776-95-1 p-[N-(4-ethoxy-2,3-dioxocyclobut-1-enyl)amino]phenyl α-D-glucopyranoside 
• 1310875-54-7 C₄₉H₅₀N₂O₁₀ 
• 91290-58-3 p-(succinylamido)phenyl α-D-glucopyranoside 

Relevant articles and documents

Modulating helicity through amphiphilicity - Tuning supramolecular interactions for the controlled assembly of perylenes

Here we show that it is possible to modulate the supramolecular assembly of designed H-bonding amphiphilic perylene-based materials through simple solvent interactions. These modulated supramolecular interactions have been translated to and observed in macroscopic properties, and provide new pathways to the preparation of switchable interfaces based on designed supramolecular interactions.

Sugar-modified cytostatics

The invention relates to cytostatics which, by modification with sugar, are tumor-specific. Suitable spacers ensure serum stability and at the same time an intracellular action.

Improvement of intestinal absorption of peptide drugs by glycosylation: Transport of tetrapeptide by the sodium ion-dependent D-glucose transporter

A tetrapeptide (Gly-Gly-Tyr-Arg, GGYR), which is not transported by di- or tripeptide transporters, was glycosylated with p-(succinylamido)phenyl α- or β-D-glucopyranoside (α,β-SAPG) to investigate whether these glycosylated molecules are transported by t